|
Neovascular glaucoma: Handling in the future
Hongfang Yang1, Xiaobo Yu1, Xinghuai Sun2
1 Department of Ophthalmology and Visual Science, Eye, Ear, Nose, and Throat Hospital, Shanghai Medical College, Fudan University, Shanghai, China
2 Department of Ophthalmology and Visual Science, Eye, Ear, Nose, and Throat Hospital, Shanghai Medical College, Fudan University; Key Laboratory of Myopia, Ministry of Health, Fudan University; Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University; Institutes of Brain Science and Collaborative Innovation Center for Brain Science, State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai, China
Correspondence Address:
Prof. Xinghuai Sun
Department of Ophthalmology and Visual Science, Eye, Ear, Nose, and Throat Hospital, Shanghai Medical College, Fudan University, 83 Fenyang Rd., Shanghai 200031
China
 Source of Support: None, Conflict of Interest: None  | 7 |
DOI: 10.4103/tjo.tjo_39_18
|
|
Neovascular glaucoma (NVG), which is refractory to both medical management and surgical intervention, is a disastrous ocular disease for it always ends up with intolerable pain and extinguishing patients' residual visual function. Since insufficient acknowledge of the pathophysiological and molecular mechanisms of NVG, it has been laying a challenging dilemma of managing NVG in clinical practice for a long time. Along with the progression on some new agents and surgical options targeting certain possible roles in the NVG process, there seems having been some new sights but still much unknown and to be revealed. This review discusses the underlying etiologic diseases of NVG, molecular findings and characteristics of its pathogenic process, as well as the management of NVG in detail. In addition, here represents some of our hypothesis regarding the interesting findings about NVG in clinical practice, aiming to provide some new enlightenment for future research.
|
